CMIC CMO USA, a contract manufacturer serving the pharmaceutical industry, has committed to a 233,000-square-foot property in Cranbury, New Jersey. The company will occupy the property on a long-term basis and will use it for office, research and development, production, packaging, manufacturing, warehousing and distribution.
The deal involved negotiating a lease termination with an existing tenant, Sun Pharmaceutical, and arranging for the purchase of in-place research and development infrastructure.
CMIC CMO was represented by Cushman & Wakefield’s Shawn Straka and Chuck Fern. Matrix Development’s VP of acquisitions, Gary Hans, represented ownership.
“The cooperation of three entities – Matrix, Sun Pharmaceutical and CMIC CMO USA – was critical to the success of this transaction,” said Fern.